{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.title}}
{{item.text}}
Compliance in the pharmaceutical industry is being transformed by six key external forces: legal, financial, technological and medical innovation, cultural, educational and demographics.
PwC developed in collaboration with compliance leaders across the industry, the “Future of Compliance Whitepaper 2023” provides agenda-setting coverage about the issues, priorities and key challenges facing pharmaceutical compliance leaders as well as emerging trends, risks and business implications.
Download this free report to find out how compliance leaders can effectively plan for the future while successfully addressing their current business needs.
What’s inside:
✓ Understand today’s key challenges.
✓ Explore cases relating to business partner and healthcare professional interactions, the benefits to be achieved and the approaches taken.
✓ Get PwC recommendations for navigating the pharmaceutical compliance transformation programme.
{{filterContent.facetedTitle}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Follow us
Contact us
UK and Global Head of Risk Services, PwC United Kingdom
Tel: +44 (0)7710 058286
Shaun Willcocks
Global Risk Markets Leader, Global Internal Audit Leader, Partner, PwC Japan
Tel: +81 (0)90 6478 6991
Global Cybersecurity & Privacy Leader, PwC US; Cyber, Risk & Regulatory Leader, PwC US
Jennifer Ho
Asia Pacific, Mainland China & Hong Kong Risk Services Leader, PwC Hong Kong
Tel: +[852] 2289 2919
Dr. Robert Paffen
Global Risk Services Digital Leader, Germany Risk & Regulatory Leader, PwC Germany
